Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports
AI Image

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

Reuters • • business

Key Points:

  • Shares of Insmed surged 14%, with the company valued at $26.28 billion according to LSEG data.
  • French drugmaker Sanofi is reportedly in talks with advisers about a potential acquisition of Insmed, as per Bloomberg sources.
  • Sanofi has declined to comment on market rumors regarding the possible deal.
  • Discussions are ongoing and any agreement could take several weeks to finalize.

Trending Business

Trending Technology

Trending Health